Dataset
Cilastatin; LC-ESI-QTOF; MS2; CE: 10 eV; R=35000; [M+H]+
Chemical Information
| InChI | InChI=1S/C16H26N2O5S/c1-16(2)8-10(16)13(19)18-12(15(22)23)6-4-3-5-7-24-9-11(17)14(20)21/h6,10-11H,3-5,7-9,17H2,1-2H3,(H,18,19)(H,20,21)(H,22,23)/b12-6-/t10-,11+/m1/s1 |
|---|---|
| SMILES | CC1(C[C@@H]1/C(=N/C(=C\CCCCSC[C@@H](C(=O)O)N)/C(=O)O)/O)C |
| InChI Key | DHSUYTOATWAVLW-WFVMDLQDSA-N |
| Molecular Formula | C16H26N2O5S |
| Exact Mass | 358.156 g/mol |
Data and Resources
Metadata Information
| Field | Value |
|---|---|
| DOI | |
| License URL | https://creativecommons.org/licenses/by/4.0 |
| Source | https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Athens_Univ-AU212901 |
| Version | |
| Author | |
| Maintainer | |
| Language | |
| MetadataPublished | 2016-02-22 |
| Related Molecule |
|
| Field | Value |
|---|---|
| Measurement Technique | liquid chromatography-mass spectrometry |
| Measurement Variables |
| Data-Source Molecule ID | Data-Source |
|---|---|
| ZINC000004095696 | ZINC |
| HMDB0015535 | Human Metabolome Database |
| MTBLC3697 | Metabolights |
| PA448998 | PharmGKB |
| SCHEMBL37051 | SureChEMBL |
| 141A6AMN38 | FDA SRS |
| PD009460 | ProbesDrugs |
| 60022061 | NMRShiftDB |
| 15447933 | PubChem: Thomson Pharma |
| 14803328 | PubChem: Thomson Pharma |
| 82009-34-5 | ACToR |
| DB01597 | DrugBank |
| CHEMBL766 | ChEMBL |
| 3697 | ChEBI |
| C01675 | KEGG Ligand |
| CILASTATIN | DailyMed |
| CILASTATIN | rxnorm |
| PRIMAXIN | rxnorm |
| CILASTATIN SODIUM | rxnorm |
| CILASTATIN SODIUM | clinicaltrials |
| CILASTATIN | clinicaltrials |
| 50367502 | BindingDB |
| HY-A0166 | MedChemExpress |
| LSM-43242 | LINCS |
| DTXSID8048238 | EPA CompTox Dashboard |
| 640 | DrugCentral |
| 5166 | Guide to Pharmacology |
| J32.849I | Nikkaji |
| MK-791 | clinicaltrials |
| 6435415 | PubChem |
| The data in this table is sourced from UniChem at EBI. | |